This content is not available in your region

Swiss drugmaker Roche again extends $4.3 billion Spark offer until December 16

Text size Aa Aa

ZURICH (Reuters) – Swiss drugmaker Roche <ROG.S> again extended its offer for shares of gene therapy specialist Spark Therapeutics <ONCE.O> to Dec. 16 as a regulatory review of the $4.3 billion (3.35 billion pounds) transaction drags on.

All terms and conditions of Roche’s offer remain unchanged, it said in a statement on Monday.

(Reporting by John Miller; editing by Thomas Seythal)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.